ZERLASIRAN 5'-MODIFICATION
UNII VTF9MMJ8CN

Substance Identification & Data

This profile provides standardized clinical and technical data for Zerlasiran 5'-modification, uniquely identified by the FDA Unique Ingredient Identifier (UNII) VTF9MMJ8CN.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

VTF9MMJ8CN

CAS Registry Number

N/A

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ZERLASIRAN 5'-MODIFICATION

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C66H122N6O38P4S4

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

ORJSJIGSEZSCDD-JOZDTAFESA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

166177242

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

O(P(O)(OC[C@H]1O[C@@H](n2c(=O)nc(N)cc2)[C@H](OC)[C@@H]1O)=S)CCCCCCOCC(COCCCOP(O)(=S)OCCCCO[C@@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3NC(C)=O)(COCCCOP(O)(=S)OCCCCO[C@@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4NC(C)=O)COCCCOP(O)(=S)OCCCCO[C@H]5[C@@H]([C@H]([C@@H](O)[C@H](O5)CO)O)NC(=O)C

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Zerlasiran 5'-modification. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

METHYLCYTIDYLYL-5'-(O-(21-((2-(ACETYLAMINO)-2-DEOXY-.BETA.-D-GALACTOPYRANOSYL)OXY)-9,9-BIS(12-((2-(ACETYLAMINO)-2-DEOXY-.BETA.-D-GALACTOPYRANOSYL)OXY)-7-MERCAPTO-7-OXIDO-2,6,8-TRIOXA-7-PHOSPHADODEC-1-YL)-16-MERCAPTO-16-OXIDO-7,11,15,17-TETRAOXA-16-PHOSPHAHENEICOS-1-YL) HYDROXY PHOSPHATE)

ZERLASIRAN 5'-MODIFICATION

External Clinical & Regulatory Resources

Previous UNIIVTF86SPQ4S

Next UNIIVTH5K8PW7U